Loading the map…

Buying and selling of own real estate · Wembley

Quantum Point

Quantum Point Ltd

Net liabilitiesCash down 60%ActiveLatest figures: 2025Abridged accountsCompany only4 years on the register

Private limited company registered in Wembley, classed under “Buying and selling of own real estate”.

Headline figures

FY to Mar 2025 · Company only

Turnover

For subscribers

Profit after tax

—

Not filed: small-company exemption

Net assets

For subscribers

Cash

For subscribers

Employees

For subscribers

Retained reserves

For subscribers

What the numbers say

2 findings from the figures, in plain English

Written by rules from the figures on this page. Not a forecast or a credit opinion.

History

Pro
£202320242025
Profit after tax—
Turnover
Net assets
Cash
Employees
Retained reserves

Every figure for all 3 years

“—” means we did not find the figure in a source; it is never filled with an estimate.

Balance sheet and ratios

From the filed balance sheets · £

Balance sheet202320242025
Creditors due within a year
Net current assets
Creditors due after a year
Ratios
Cash ratioCash for every £1 owed within a year

3 balance-sheet lines and 1 ratios, every year

A ratio appears only for years where every line it needs was filed. Lines are as tagged in the accounts; nothing is added up or estimated.

Questions people ask

›What does Quantum Point do?

Private limited company registered in Wembley, classed under “Buying and selling of own real estate”.

›How much turnover does Quantum Point make?

Answered in the full report

›Is Quantum Point profitable?

Quantum Point's profit isn't public: small companies may file without a profit and loss account.

›How many people work at Quantum Point?

Answered in the full report

›Where is Quantum Point based?

Its registered office is 11a Empire Parade, Empire Way, Wembley, HA9 0RQ, in Wembley.

›When was Quantum Point founded?

Quantum Point Ltd was incorporated on 22 April 2022.

›Is Quantum Point still trading?

The register lists Quantum Point Ltd as active.